Track-1 (Emerald 2): Synthesis & Screening of Drugs & Phytochemicals Agenda

Registration

Inauguration

Chairman's Welcome and Inaugural Talk

Renaissance in Pharmacognosy:The Need is Great and the Time is Now
Rathnam Chaguturu, CEO, Innovation Czar-iDDPartners, United States of America

Memento Presentation

Coffee Break and Networking in Exhibition Area

Novel Heterocyclic Construction Using N-Heterocyclic Carbene Organocatalysis
Akkattu Biju, Senior Scientist, National Chemical Laboratory, India

DNA-Targeted Anticancer Agents: Molecular Design and their Synthesis
N Shankaraiah, Assistant Professor, NIPER, Hyderabad, India

Nanodrug Delivery in Reversing Multidrug Resistance in Cancer Cells
Mayur Yergeri, Professor & Prinicipal, Dr Bhanuben Nanavati College of Pharmacy, India

Technology Spotlight:
Drug Discovery & Development: The Dilemma of Investing in Software Solutions
K K Bhagchandani, Director, Advanced Chemistry Development Inc

Lunch and Networking in Exhibition Area

Dundee, Drug Discovery Unit: Novel Targets and Small Molecule Inhibitors
Ian Gilbert, Head of Chemistry, University of Dundee, United Kingdom

Coffee Break and Networking in Exhibition Area

Open-Source Chemoinformatics for Virtual Screening in Drug Discovery
Muthukumarasamy Karthikeyan, Principal Scientist, National Chemical Laboratory, India

Pharmacophore Modeling and Molecular Docking Based Thriving Protocol for Target Identification
Vijay Masand, Assistant Professor, Vidya Bharti College, India

End of First Day of Conference

FREE WORKSHOP: RNA Silencing for Drug Discovery- Challenges and Strategies

Special Lecture: Moving from Single Drug to Formulation Discovery
Bhushan Patwardhan, Professor & Director- ISHS, University of Pune, India

Natural Products for Drug Discovery and Development: Inspiration from the " Ancient Wisdom of Mother Nature"
Mukund Chorghade, President & CSO, Chorghade Enterprises, United States of America

Coffee Break and Networking in Exhibition Area

"NMITLI Arthritis Model" (Validating Ayurvedic Drugs for Global Use)
Arvind Chopra, Director and Chief Rheumatologist, Center for Rheumatic Diseases, India

Natural Products as New Sources of Drug and Nutraceutical Discovery
Lal Hingorani, Chairman/ Managing Director, Pharmanza Herbal Pvt. Ltd, India

Plenary Presentation: High-throughput In vivo Vertebrate Screening: An Automation Point of View
Giancarlo Basile, Editor in Chief, Current Research in Drug Discovery, Italy

Discovery of Novel Compounds for the Treatment of Drug Resistant and Persistent Tuberculosis
Rajkumar Halder, Scientist E, Translational Health Science and Technology Institute, India

High Content Image- Based Screening of a Protease Inhibitor Library Reveals Compounds Broadly Active against Multiple Highly Pathogenic RNA Viruses
Krishna Kota, Scientist, PerkinElmer, United States of America

Technology Spotlight:
Leveraging the Power of High Throughput Screening to Identify a Diastereomeric Salt for Chiral Resolution
David Yamane, Product Marketing Director, Freeslate Inc

Lunch and Networking in Exhibition Area

POSTER EVALUATION

Accelerated and Reliable Lead Discovery: Structure Guided Drug Discovery Ideal for Collaborative Projects
Kal Ramnarayan, President and Chief Scientific Officer, Sapient Discovery, United States of America

Opportunities for Strategic Research Partnerships in Drug Discovery
Ajith Kamath, Head, Pfizer Inc, India

Crowdsourcing Systems Level Platforms for Open Source Drug Discovery
Anshu Bhardwaj, Scientist, CSIR- Open Drug Discovery Unit, India

Open Source Drug Discovery for Tuberculosis: Lessons to learn
Anamik Shah, Vice Chancellor, Gujarat Vidyapith, India

Open Discussion on Open Source Drug Discovery

Coffee Break and Networking in Exhibition Area

Panel Discussion: Drug Discovery- Contract Research Landscape in India 2020

End of the Conference